The First CAR-T Drugs Have Left the Gate – Madison.com
Madison.com |
The First CAR–T Drugs Have Left the Gate
Madison.com CAR-T treatments take T cells out of a patient, genetically modify the cells so they're programmed to attack tumor cells expressing a specific protein, and then infuse them back into the patients to attack the cancerous cells. Both Novartis' and Kite … |
